Researcher Profile

Kang, Min Ho image
Kang, Min Ho (강민호) 14

Personalized Genomic Medicine Research Center (유전체맞춤의료전문연구단)

Keywords Cloud

KRIBB Co-Working

Results 1-14 of 14 (Search time: 0.002 seconds).

No. Year Title Type
14 2019

2019Article

Lactate activates the E2F pathway to promote cell motility by up-regulating microtubule modulating genesCancers, vol. 11, no. 3, pp. 274-274Yi Deun Jung; Jung Hee Cho; Seulki Park; Minho Kang; Seung Jin Park; Dong Hee Choi; Moonkyung Jeong; Kyung Chan ParkYoung Il YeomDong Chul Lee
Article
13 2019

2019Article

Higd-1a regulates the proliferation of pancreatic cancer cells through a pERK/p27KIP1/pRB pathwayCancer Letters, vol. 461, pp. 78-89H J An; M Ryu; H J Jeong; Minho Kang; H M Jeon; J O Lee; Y S Kim; H Lee
Article
12 2018

2018Patent

NDRG3 발현 또는 활성 억제제를 유효성분으로 함유하는 염증질환 예방 및 치료용 약학적 조성물KR10-2014-0063002 (2014.05.26) / 10-1904343 (2018.09.27)염영일박경찬; 손현암; 강민호이동철
Patent
11 2018

2018Article

RNF25 promotes gefitinib resistance in EGFR-mutant NSCLC cells by inducing NF-κB-mediated ERK reactivationCell Death & Disease, vol. 9, no. 6, pp. 587-587Jung Hee Cho; Yeon Mi You; Young Il YeomDong Chul LeeBo Kyung KimMi Sun Won; B C Cho; Mingho Kang; Seulki Park; Suk-Jin Yang, et al.
Article
10 2017

2017Patent

NDRG3 단백질을 이용한 젖산의 정량 방법KR10-2015-0053425 (2015.04.15) / 10-1767605 (2017.08.07)염영일박경찬; 손현암; 강민호이동철
Patent
9 2017

2017Patent

NDRG3 발현 또는 활성 억제제를 유효성분으로 함유하는 암 예방 및 치료용 약학적 조성물KR10-2014-0063014 (2014.05.26) / 10-1721492 (2017.03.24)염영일박경찬; 손현암; 강민호이동철
Patent
8 2017

2017Patent

NDRG3 과발현 형질전환 동물모델 및 이의 용도KR10-2014-0062986 (2014.05.26) / 10-1695740 (2017.01.06)염영일박경찬; 손현암; 강민호이동철
Patent
7 2017

2017Article

Regulation of hypoxia responses by flavin adenine dinucleotide-dependent modulation of HIF-1α protein stability = FAD 의존적인 HIF-1a 단백질 안정성 제어를 통한 저산소반응 조절 기전EMBO Journal, vol. 36, no. 8, pp. 1011-1028Suk Jin Yang; Young Soo Park; Jung Hee Cho; Byul Moon; Hyun Jung Ahn; J Y Lee; Z Xie; Y Wang; D Pocalyko; Dong Chul Lee, et al.
Article
6 2016

2016Patent

NDRG3 발현 또는 활성 촉진제를 유효성분으로 함유하는 허혈성 질환 예방 및 치료용 약학적 조성물KR10-2015-0053453 (2015.04.15) / 10-1663029 (2016.09.29)염영일박경찬; 손현암; 강민호이동철
Patent
5 2016

2016Patent

NDRG3 단백질 특이적인 항체 및 이의 용도KR10-2014-0062966 (2014.05.26) / 10-1609843 (2016.03.31)염영일박경찬; 손현암; 강민호이동철
Patent
4 2016

2016Article

High-resolution transcriptome analysis reveals neuropathic pain gene-expression signatures in spinal microglia after nerve injuryPain, vol. 157, no. 4, pp. 964-976H Jeong; Y J Na; K Lee; Y H Kim; Y Lee; Min Ho Kang; B C Jiang; Young Il Yeom; L J Wu; Y J Gao, et al.
Article
3 2015

2015Article

A lactate-induced response to hypoxia = 젖산 매개 저산소 반응Cell, vol. 161, no. 3, pp. 595-609Dong Chul Lee; Hyun Ahm Sohn; Z Y Park; Sangho Oh; Y K Kang; K M Lee; Min Ho Kang; Ye Jin Jang; Suk Jin Yang; Young Ki Hong, et al.
Article
2 2014

2014Article

Donor-derived natural killer cells infused after human leukocyte antigen-haploidentical hematopoietic cell transplantation: a dose-escalation studyBiology of Blood and Marrow Transplantation, vol. 20, no. 5, pp. 696-704In Pyo ChoiSuk Ran Yoon; Soo Yeon Park; Hanna KimSol-Ji Jung; Ye Jin Jang; Min Ho KangYoung Il Yeom; J L Lee; D Y Kim, et al.
Article
1 2013

2013Article

Metabolic signature genes associated with susceptibility to pyruvate kinase, muscle type 2 gene ablation in cancer cellsMolecules and Cells, vol. 35, no. 4, pp. 335-341Yuri Jung; Y J Jang; Min Ho Kang; Young Soo Park; Su Jin Oh; Dong Chul Lee; Z Xie; H S Yoo; Kyung Chan ParkYoung Il Yeom
Article
1